Latest News

Neurodegenerative disease advance: Study details how brain enzyme interacts with drug-like lead compound for Huntington's

A significant breakthrough has been made towards developing an effective treatment for neurodegenerative diseases such as Huntington's, Alzheimer's and Parkinson's. Researchers have detailed how an enzyme in the brain interacts with a promising drug-like lead compound for Huntington's disease to inhibit its activity. Their findings demonstrate that it can be developed as an effective treatment for neurodegenerative diseases.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Using Twitter to probe political polarization

  • Wobbly no more: Work on analogical processing helps children learn key engineering principle

  • How are ordinary consumers transforming the fashion business?

  • When are consumers more likely to rely on feelings to make decisions?

  • Saving money: Do consumers spend less if they think about the future?

  • Cultivating timeflow: Can consumers shape how they experience time?

  • Scientists one step closer to finding how to repair damaged nerve cells

  • Chronic loneliness in older adults leads to more doctors' office visits, study finds

  • Do consumers think products are better when companies donate to charity?

  • A matter of taste: When do products benefit from mixed reviews?

  •